Cargando…
Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study
INTRODUCTION: COVID-19 induces coagulopathy associated with an increase of thromboembolic events. Due to the lack of agreement on recommendations for thromboprophylactic management, the aim of this study was to study the dosages of LMWH used in critically ill COVID-19 patients assessing the effect o...
Autores principales: | Ferrandis, R., Escontrela, B., Ferrando, C., Hernández, M., Herrera, J., Hidalgo, F., Librero, J., Llau, J.V., Martínez, A., Pajares, A., Tapia, B., Arruti, E., Bassas, E., Blasi, A., Calvo, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Published by Elsevier España, S.L.U.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957653/ https://www.ncbi.nlm.nih.gov/pubmed/36842685 http://dx.doi.org/10.1016/j.redare.2023.02.004 |
Ejemplares similares
-
Eficacia de la tromboprofilaxis con heparina de bajo peso molecular en pacientes críticos con COVID-19: estudio observacional, prospectivo y multicéntrico
por: Ferrandis, R., et al.
Publicado: (2023) -
COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
por: Ferrandis, Raquel, et al.
Publicado: (2020) -
Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey
por: Ferrandis, Raquel, et al.
Publicado: (2021) -
Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis
por: Matsumoto, Mio, et al.
Publicado: (2015) -
Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome?
por: Gurjar, Mohan
Publicado: (2014)